Alcohol use accelerates HIV disease progression.
The effects of alcohol abuse on HIV disease progression have not been definitively established. A prospective, 30-month, longitudinal study of 231 HIV(+) adults included history of alcohol and illicit drug use, adherence to antiretroviral therapy (ART), CD4(+) cell count, and HIV viral load every 6 months. Frequent alcohol users (two or more drinks daily) were 2.91 times (95% CI: 1.23-6.85, p = 0.015) more likely to present a decline of CD4 to <or=200 cells/microl, independent of baseline CD4(+) cell count and HIV viral load, antiretroviral use over time, time since HIV diagnosis, age, and gender. Frequent alcohol users who were not on ART also increased their risk for CD4 cell decline to <or=200 cells/mm(3) (HR = 7.76: 95% CI: 1.2-49.2, p = 0.03). Combined frequent alcohol use with crack-cocaine showed a significant risk of CD4(+) cell decline (HR = 3.57: 95% CI: 1.24-10.31, p = 0.018). Frequent alcohol intake was associated with higher viral load over time (beta = 0.259, p = 0.038). This significance was maintained in those receiving ART (beta = 0.384, p = 0.0457), but not in those without ART. Frequent alcohol intake and the combination of frequent alcohol and crack-cocaine accelerate HIV disease progression. The effect of alcohol on CD4(+) cell decline appears to be independent of ART, through a direct action on CD4 cells, although alcohol and substance abuse may lead to unmeasured behaviors that promote HIV disease progression. The effect of alcohol abuse on viral load, however, appears to be through reduced adherence to ART.
Baum
Marianna K
MK
Florida International University, Robert Stempel College of Public Health and Social Work, Miami, Florida 33199, USA. baumm@fiu.edu
Rafie
Carlin
C
Lai
Shenghan
S
Sales
Sabrina
S
Page
John Bryan
JB
Campa
Adriana
A
D000328:Adult; D000428:Alcohol Drinking; D000437:Alcoholism / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology* / Q000821:virology; D015497:HIV-1; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D019966:Substance-Related Disorders / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D011795:Surveys and Questionnaires; D019562:Viral Load
D019380:Anti-HIV Agents
Alcohol Clin Exp Res. 2002 Jun;26(6):907-15
12068261
Alcohol Clin Exp Res. 1998 Apr;22(2):474-80
9581656
J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):93-9
19295339
Gastroenterology. 1999 Jul;117(1):181-90
10381926
AIDS Behav. 2007 Mar;11(2):185-94
16897351
Psychiatr Pol. 2002;36(2):293-302
12043046
Alcohol Alcohol. 1992 Jul;27(4):417-24
1358081
J Infect Dis. 1993 Apr;167(4):789-97
8450242
J Hepatol. 1997 Jul;27(1):96-102
9252080
J Natl Med Assoc. 1993 Apr;85(4):293-6
8478971
Alcohol Clin Exp Res. 2006 Oct;30(10):1781-90
17010145
AIDS. 2002 Mar 29;16(5):767-74
11964533
Alcohol Clin Exp Res. 2004 Apr;28(4):572-7
15100608
Am J Epidemiol. 2006 Mar 1;163(5):412-20
16394200
Gastroenterology. 1995 Jan;108(1):193-200
7806041
J Nutr Sci Vitaminol (Tokyo). 2005 Apr;51(2):99-103
16022196
Alcohol Clin Exp Res. 2008 Jan;32(1):138-47
18028526
AIDS. 2002 Nov 8;16(16):2175-82
12409739
J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):521-5
12869842
AIDS Res Hum Retroviruses. 2004 Feb;20(2):151-5
15018702
Alcohol Clin Exp Res. 1989 Oct;13(5):636-43
2574543
Am J Epidemiol. 1990 Oct;132(4):717-22
2403112
J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):92-3
11064510
AIDS. 1999 Feb 4;13(2):257-62
10202832
Front Biosci. 2002 Jul 1;7:d1689-96
12086912
Alcohol Alcohol. 1994 Mar;29(2):131-9
8080593
Pharmacopsychiatry. 2005 Mar;38(2):95-6
15744633
Alcohol. 1995 Nov-Dec;12(6):547-52
8590617
Alcohol Clin Exp Res. 1992 Oct;16(5):846-51
1443419
Alcohol Clin Exp Res. 2006 Dec;30(12):2065-78
17117972
Immunology. 2003 Mar;108(3):313-20
12603597
J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):194-9
17667330
J Gen Intern Med. 2002 May;17(5):377-81
12047736
Addict Biol. 2003 Mar;8(1):33-7
12745413
J Infect Dis. 1992 Jan;165(1):75-9
1727899
Am J Epidemiol. 1994 Oct 15;140(8):747-58
7942776
JAMA. 1989 Jun 16;261(23):3424-9
2524608
Addiction. 2004 Mar;99(3):361-8
14982549
Alcohol. 1997 Mar-Apr;14(2):155-9
9085716